ATE355527T1 - Methoden zur diagnostizierung oder zur behandlung der alzheimer-krankheit - Google Patents
Methoden zur diagnostizierung oder zur behandlung der alzheimer-krankheitInfo
- Publication number
- ATE355527T1 ATE355527T1 AT00929471T AT00929471T ATE355527T1 AT E355527 T1 ATE355527 T1 AT E355527T1 AT 00929471 T AT00929471 T AT 00929471T AT 00929471 T AT00929471 T AT 00929471T AT E355527 T1 ATE355527 T1 AT E355527T1
- Authority
- AT
- Austria
- Prior art keywords
- disease
- activity
- level
- subject
- diagnosing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4709—Amyloid plaque core protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
- G01N2333/48—Nerve growth factor [NGF]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99108722A EP1050757A1 (de) | 1999-05-03 | 1999-05-03 | Methoden zur Diagnostizierung oder zur Behandlung von neuropsychiatrischen Erkrankungen, die auf erhöhten Nervenwachstumsfaktor (NGF)-Spiegel basiert sind |
EP99120211 | 1999-10-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE355527T1 true ATE355527T1 (de) | 2006-03-15 |
Family
ID=26152988
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00929471T ATE355527T1 (de) | 1999-05-03 | 2000-05-02 | Methoden zur diagnostizierung oder zur behandlung der alzheimer-krankheit |
Country Status (6)
Country | Link |
---|---|
US (1) | US20050130233A1 (de) |
EP (1) | EP1173769B1 (de) |
AT (1) | ATE355527T1 (de) |
AU (1) | AU4753900A (de) |
DE (1) | DE60033646T2 (de) |
WO (1) | WO2000067033A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004020666A2 (en) * | 2002-09-02 | 2004-03-11 | Evotec Neurosciences Gmbh | Diagnostic and therapeutic use of thyroid hormone binding protein for neurodegenerative diseases |
CA2501945A1 (en) * | 2002-10-09 | 2004-04-22 | Rinat Neuroscience Corp. | Methods of treating alzheimer's disease using antibodies directed against amyloid beta peptide and compositions thereof |
EA016357B1 (ru) * | 2004-07-30 | 2012-04-30 | Ринат Ньюросайенс Корп. | Антитела, направленные против бета-амилоидного пептида, и способы их применения |
MY148086A (en) * | 2005-04-29 | 2013-02-28 | Rinat Neuroscience Corp | Antibodies directed against amyloid-beta peptide and methods using same |
JP2007151680A (ja) * | 2005-12-01 | 2007-06-21 | Hi-Lex Corporation | スカフォールド材料 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1243281B (it) * | 1990-06-12 | 1994-05-26 | Fidia Spa | Metodo per la determinazione quantitativa e qualitativa di polipeptidiin liquidi proteici |
WO1994019461A1 (en) * | 1993-02-17 | 1994-09-01 | Cephalon, Inc. | METHOD FOR IDENTIFYING COMPOUNDS THAT INDUCE AN INCREASED LEVEL OF THE NERVE GROWTH FACTOR mRNA |
-
2000
- 2000-05-02 EP EP00929471A patent/EP1173769B1/de not_active Expired - Lifetime
- 2000-05-02 AT AT00929471T patent/ATE355527T1/de not_active IP Right Cessation
- 2000-05-02 WO PCT/EP2000/003913 patent/WO2000067033A1/en active IP Right Grant
- 2000-05-02 DE DE60033646T patent/DE60033646T2/de not_active Expired - Fee Related
- 2000-05-02 AU AU47539/00A patent/AU4753900A/en not_active Abandoned
-
2004
- 2004-11-15 US US10/987,298 patent/US20050130233A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU4753900A (en) | 2000-11-17 |
DE60033646T2 (de) | 2007-11-29 |
US20050130233A1 (en) | 2005-06-16 |
EP1173769A1 (de) | 2002-01-23 |
DE60033646D1 (de) | 2007-04-12 |
EP1173769B1 (de) | 2007-02-28 |
WO2000067033A1 (en) | 2000-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE462710T1 (de) | Mutationen in nod2 sind bei patienten mit morbus crohn mit fibrostenosebildung assoziiert | |
DE60233485D1 (de) | Verfahren zur diagnose, behandlung und prävention von knochenverlust | |
DE60325617D1 (de) | Verfahren zur diagnose von bauchspeicheldrüsenkrebs | |
ATE502119T1 (de) | Verfahren zur bewertung pathologischer krankheitszustände unter verwendung extrazellulärer rna | |
ATE283487T1 (de) | Verfahren zur diagnose oder prognose von altersbedingter maculadegeneration | |
DE69510336D1 (de) | Verfahren zur diagnose von praeklampsie | |
WO2007015113A3 (en) | New protein isoforms of the pif-family and uses thereof | |
IL142971A0 (en) | S100 proteins and autoantibodies as serum markers for cancer | |
ATE355527T1 (de) | Methoden zur diagnostizierung oder zur behandlung der alzheimer-krankheit | |
DE60122673D1 (de) | Methoden zur diagnose und behandlung von herzkrankheiten | |
ATE286253T1 (de) | Methoden zur diagnose oder prognose der alzheimerschen krankheit | |
DE60038614D1 (de) | Verfahren zur diagnose von synovialen oder osteoartikulären erkrankungen | |
ATE546547T1 (de) | Diagnose der chronischen abstossung | |
DE60234958D1 (de) | Psoriasin-expression durch brustepithelzellen | |
ATE449964T1 (de) | DIAGNOSTISCHE VERWENDUNG VON ßENSADIN-0477ß FÜR NEURODEGENERATIVE ERKRANKUNGEN | |
ATE343793T1 (de) | Methode zur diagnostizierung, prognose oder evaluation von behandlung der depressionen, basiert auf erhöhte neurotrophin concentrationen in zerebrospinale flüssigkeit. | |
ATE401576T1 (de) | Verwendung eines zum kern beschränkten protein für die diagnose und therapie von alzheimer- krankheit und relatierte neurodegeneratiefe störungen | |
ATE410521T1 (de) | Ex-vivo-verfahren zur bestimmung der cetp- aktivität und der wirksamkeit der behandlung von herzerkrankungen | |
DE69912453D1 (de) | Verfahren und materialien zur diagnose instabiler angina | |
FI951778A (fi) | Menetelmä allergian toteamiseksi | |
DE60238055D1 (de) | Verfahren zur diagnose einer person mit multipler sklerose | |
DE602005023973D1 (de) | Verfahren zur diagnose von chronischem stress und verwandten erkrankungen | |
RU2188429C2 (ru) | Способ прогнозирования обострений вирусных гепатитов | |
HUP0301944A2 (hu) | Alkoholizmus kialakulása kockázatának diagnosztizálása személyekben | |
WO2005034735A3 (en) | Method for assessing the risk for insulin resistant diabetes and/or heart disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |